Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries. Its strategy is based upon three elements: healthcare and life science industry specialization, integrated private equity and operating expertise, and strategic relationships with large corporations. The Company invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. Linden has invested more than $1 billion in healthcare and life science companies, helping to build strong platforms and thriving businesses. It manages $1.3 billion in assets augmented by capital provided by Limited Partners for larger transactions.